title: Contribution of peripheral versus central EP1 prostaglandin receptors to inflammatory pain.
abstract: Prostaglandin E(2) (PGE(2)) is a key mediator of exaggerated pain sensation during inflammation. Drugs targeting the PGE(2) pathway by global inhibition of cyclooxygenases are well established in the treatment of inflammatory pain, but also cause significant unwanted effects. Enzymes downstream of the cyclooxygenases, or prostaglandin receptors are candidate targets possibly enabling therapeutic intervention with potentially fewer side effects. Among the PGE(2) receptors, the EP1 subtype has repeatedly been proposed as a promising target for treatment of inflammatory hyperalgesia. However its involvement in sensitization at specific (peripheral or central) sites has not been thoroughly investigated. Here, we have used mice deficient in the EP1 receptor (EP1(-/-)) to address this issue. EP1(-/-) mice showed normal mechanical and heat sensitivity during baseline conditions. Local subcutaneous PGE(2) injection into one hindpaw, caused thermal and mechanical sensitization in wild-type mice and EP1(-/-) mice. Thermal sensitization in EP1(-/-) mice was less than in wild-type mice while no significant difference was seen for mechanical sensitization. Injection of PGE(2) into the subarachnoid space of the lumbar spinal cord, resulted in a similar mechanical sensitization in EP1(-/-) mice and in wild-type mice, while a tendency towards reduced reaction to noxious heat stimulation was observed in EP1(-/-) mice. These results support a major contribution of EP1 receptors to peripheral heat sensitization, but only a minor role in mechanical sensitization and in spinal heat sensitization by PGE(2). After local subcutaneous zymosan A injection, EP1(-/-) mice showed indistinguishable mechanical and heat sensitization compared with wild-type mice. Taken together, these results suggest that peripheral EP1 receptors contribute significantly to inflammation induced heat pain sensitization while evidence for a contribution to central sensitization was not obtained.
authors: Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
authors: Torbjörn
authors: T
authors: Johansson
authors: Shuh
authors: S
authors: Narumiya
authors: Hanns Ulrich
authors: HU
authors: Zeilhofer
mesh_terms: D000818:Animals; D015232:Dinoprostone / Q000494:pharmacology; D006358:Hot Temperature; D007249:Inflammation / Q000378:metabolism; D008024:Ligands; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010146:Pain / Q000378:metabolism* / Q000523:psychology; D017288:Pain Threshold; D017933:Peripheral Nervous System / Q000378:metabolism* / Q000503:physiopathology; D058306:Receptors, Prostaglandin E, EP1 Subtype / Q000235:genetics / Q000502:physiology*; D013116:Spinal Cord / Q000378:metabolism* / Q000503:physiopathology; D014110:Touch; D015054:Zymosan / Q000494:pharmacology
chemical_list: D008024:Ligands; D058306:Receptors, Prostaglandin E, EP1 Subtype; D015054:Zymosan; D015232:Dinoprostone